Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
Seeking Alpha
Thursday, December 26, 2013 - 9:43am
tags:
eteplirsen, Sarepta Therapeutics, Duchenne Muscular Dystrophy
Exclusive: Carlyle near deal to buy J&J diagnostics unit - sources
Reuters
Tuesday, December 24, 2013 - 9:52am
tags:
Carlyle, JNJ, diagnostics, M&A
FDA rejects Actavis' contraceptive patch, asks for more data
Reuters
Tuesday, December 24, 2013 - 9:51am
tags:
FDA, Actavis, contraceptive patch
Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tuesday, December 24, 2013 - 9:50am
tags:
Big Pharma, drug stocks, Merck, JNJ, GSK, Eli Lilly, Pfizer, Sanofi, Bristol-Myers Squibb
Is AstraZeneca plc Set For Electrifying Earnings Growth In 2014?
Motley Fool, UK
Tuesday, December 24, 2013 - 9:48am
tags:
AstraZeneca
Is Amarin's Luck About to Change?
Motley Fool
Tuesday, December 24, 2013 - 9:48am
tags:
Amarin, Vascepa
Glenmark Goes West for $250 Billion Drugs Opportunity
Bloomberg
Tuesday, December 24, 2013 - 9:47am
tags:
Glenmark, India, ulcerative colitis
Who Will Win The Stem Cell Race?
Seeking Alpha
Tuesday, December 24, 2013 - 9:45am
tags:
stem cells, Cytori, Athersys, Thermogenesis, Mesoblast, NeoStem
Jazz Pharmaceuticals - Another Deal, Shareholders Are Cheering
Seeking Alpha
Tuesday, December 24, 2013 - 9:42am
tags:
Jazz Pharmaceuticals, Gentium, M&A
GlaxoSmithKline wins FDA 'breakthrough' tag for malaria treatment
Fierce Biotech
Monday, December 23, 2013 - 3:25pm
tags:
malaria, breakthrough therapies, GSK, tafenoquine
FDA smacks Hospira with nearly 2 dozen observations at India plant
Fierce Pharma
Monday, December 23, 2013 - 3:24pm
tags:
India, Hospira, FDA
Actelion gets second boost for Opsumit with EU approval
Fierce Pharma
Monday, December 23, 2013 - 3:23pm
tags:
Actelion, Opsumit, Europe, Tracleer, PAH, pulmonary arterial hypertension
FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
Yahoo/Fly on the Wall
Monday, December 23, 2013 - 3:22pm
tags:
Novo Nordisk, Tretten, FDA, congenital Factor XIII A-subunit deficiency
Update on Endo's Acquisition Strategy
Yahoo/Zacks.com
Monday, December 23, 2013 - 12:05pm
tags:
M&A, Endo Health Solutions
United Therapeutics Shares Gain on FDA Hypertension Approval
Bloomberg
Monday, December 23, 2013 - 11:27am
tags:
FDA, United Therapeutics, PAH, pulmonary arterial hypertension
The Affordable Care Act Gives Drugmakers A Boost: CMS
Pharmalot
Monday, December 23, 2013 - 11:24am
tags:
Affordable Care Act
Bristol-Myers sale of diabetes franchise positive, says BMO Capital
The Fly on the Wall
Monday, December 23, 2013 - 11:12am
tags:
diabetes, M&A, Bristol-Myers Squibb, AstraZeneca
The Avorn-Stossel Debate On GSK Halting Payment To Doctors For Drug Promotion
Forbes
Monday, December 23, 2013 - 11:02am
tags:
GSK, physician payments
Elliott denies it may accept McKesson's Celesio bid
Reuters
Monday, December 23, 2013 - 11:01am
tags:
Celesio, McKesson, M&A
Tesaro nausea drug effective in late-stage trials
Reuters
Monday, December 23, 2013 - 11:00am
tags:
Tesaro, rolapitant, chemotherapy-induced nausea and vomiting

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.